Results 111 to 120 of about 120,013 (263)

Subclinical cardiac alterations and cardiometabolic profile in adolescents with newly diagnosed polycystic ovary syndrome: A cross‐sectional comparative echocardiographic study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective While cardiometabolic comorbidities have been well established in adults with polycystic ovary syndrome (PCOS), it remains unclear whether the early signs of cardiovascular morbidity emerge during adolescence. This study aimed to investigate whether metabolic and cardiovascular alterations begin in adolescents with PCOS.
Demet Aygün Ari, Melis Pehlivantürk Kizilkan, Musa Öztürk, İlker Ertuğrul, Hayrettin Hakan Aykan, Tevfik Karagöz, Nuray Kanbur, Orhan Derman, Sinem Akgül   +8 more
wiley   +1 more source

Maternal and perinatal outcomes of pregnant women with echocardiographically high probability of pulmonary arterial hypertension

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study aimed to describe maternal and perinatal outcomes among pregnant women with echocardiographically high probability of pulmonary arterial hypertension (PAH) managed at a quaternary center and to compare outcomes between women with and without cardiac complications (CC).
Laura Belmont‐Rojo, Rosa Hernandez‐Cruz, Ana Jimena Lopez‐Diaz, Diana Yazmin Copado‐Mendoza, Tirso Rubalcava‐Rubalcava, Mario Isaac Lumbreras‐Marquez, Maria Antonia Pijuan‐Domenech   +6 more
wiley   +1 more source

Incidence of Papaverine-Induced Ventricular Arrhythmias. [PDF]

J Am Heart Assoc
Corradetti S, Munhoz D, Kodeboina M, Mahendiran T, Bermpeis K, Gallinoro E, Mizukami T, Hausmann R, De Bruyne B, Wilgenhof A, Collet C.   +10 more
europepmc   +1 more source

Beyond Traditional Screening: The Future of Heart Failure Detection With Biomarkers and AI

iNew Medicine, EarlyView.
Advancing HF Screening: Integrating Technology and Risk Factors Across Eras. This diagram provides a comprehensive review of the historical developments and projected trends of heart failure (HF) screening methodologies, with the prevalent risk factors for HF depicted at the base.
Xiaofeng Fang, Yinbo Xu, Yiting Zhao, Liuyi Li, Zhengyi Cheng, Zhongqi Zhang, Yuhang Luo, Qiaoling Liu, Chen Gong, Shichun Shen   +9 more
wiley   +1 more source

Left Ventricular Hypertrabeculation and Ventricular Arrhythmias. [PDF]

J Clin Med
Alfieri M, Principi S, Barbarossa A, Paolini F, Torselletti L, Coraducci F, Belleggia S, Coretti F, Compagnucci P, Stronati G, Casella M, Russo AD, Guerra F.   +12 more
europepmc   +1 more source

Genetic Biomarkers in the Risk Assessment of Sudden Cardiac Events: A Personalized Approach

iNew Medicine, EarlyView.
Genetic insights into the risk assessment of sudden cardiac events. ABSTRACT Sudden cardiac events are the leading cause of death worldwide. Conventional risk stratification methods, which largely depend on clinical history, imaging, and electrocardiography, are usually inadequate for identifying high‐risk individuals, especially those without visible ...
Shrikant Verma, Sushma Verma, Mohammad Abbas, Tabrez Faruqui, Bashir Ahmad Mir, Farzana Mahdi   +5 more
wiley   +1 more source

Idiopathic Ventricular Arrhythmias: Map Meticulously, Ablate Sparingly. [PDF]

Arrhythm Electrophysiol Rev
John RM.
europepmc   +1 more source

Compressed Sensing‐Accelerated 3.0 T Noncontrast‐Enhanced CMRA: Diagnostic Efficacy for Coronary Artery Stenosis

iRADIOLOGY, EarlyView.
This bar chart illustrates the diagnostic performance of coronary magnetic resonance angiography (CMRA) for detecting ≥ 50.00% coronary artery stenosis at the segment, vessel, and patient levels, including sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.
Zhengfu Wang, Yue Zhu, Yi Yin, Zewang Li, Mingming Huang, Bo Gao   +5 more
wiley   +1 more source

Management of Idiopathic Outflow Tract Ventricular Arrhythmias. [PDF]

Arrhythm Electrophysiol Rev
Enriquez AD.
europepmc   +1 more source

The Effects of Angiotensin Receptor Neprilysin Inhibitor on Endoplasmic Reticulum Stress in Doxorubicin‐Mediated Cardiomyopathy‐Associated Heart Failure Model in Rats

Journal of Applied Toxicology, EarlyView.
ABSTRACT One of the most serious complications associated with the use of the chemotherapeutic agent doxorubicin (DOX) is cardiomyopathy. Although cardioprotective drugs such as angiotensin receptor‐neprilysin inhibitors (ARNI) are used to prevent cardiomyopathy in DOX patients, no studies have reported the relationship between ARNI and endoplasmic ...
Mert Unvan, Meryem İlkay Karagül, Hatice Oruç Demirbağ, Ebru Balli   +3 more
wiley   +1 more source